Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart

Aim: Vildagliptin (vild) improves diastolic dysfunction and is associated with a lower relative risk of major adverse cardiovascular events in younger patients. The present study aimed to evaluate whether vild prevents the development of diabetic cardiomyopathy in type 2 diabetic mice and identify i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaochen, Meng, Cheng, Han, Fei, Yang, Juhong, Wang, Jingyu, Zhu, Yanjuan, Cui, Xiao, Zuo, Minxia, Xu, Jie, Chang, Baocheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013777/
https://www.ncbi.nlm.nih.gov/pubmed/33815116
http://dx.doi.org/10.3389/fphar.2021.634365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013777/
https://www.ncbi.nlm.nih.gov/pubmed/33815116
http://dx.doi.org/10.3389/fphar.2021.634365

Ejemplares similares